Local News ‘Sci-Fi’ Tech Allows Activation of Brain Cells in Mice UW Medicine | December 15, 2023 Using lasers and a holographic two-photon microscope that can peer deep into the brain, a…karnottDecember 15, 2023 Read More
Local News BBI & UW Medicine Launch ‘New Age of Experimentation’ with Allen Institute and Chan Zuckerberg Initiative Brotman Baty Institute | December 15, 2023 The Allen Institute, the Chan Zuckerberg Initiative and the University of Washington announced today, Dec.…karnottDecember 15, 2023 Read More
Local News Pfizer Wins Regulatory Approval for Its $43B Acquisition of Seattle-Area Biotech Giant Seagen GeekWire | December 14, 2023 Pfizer’s plan to acquire Seagen for $43 billion has cleared the necessary regulatory hurdles, the…karnottDecember 14, 2023 Read More
Local News Washington Research Foundation Announces Its Largest Ever Cohort of WRF Postdoctoral Fellows for 2024 Washington Research Foundation | December 14, 2023 Washington Research Foundation (WRF) has awarded 15 three-year WRF Postdoctoral Fellowships to begin in 2024.…karnottDecember 14, 2023 Read More
Local News Scientists Unveil First Complete Cellular Map of Adult Mouse Brain Allen Institute | December 14, 2023 Six years and 32 million cells later, scientists have created the first full cellular map…karnottDecember 14, 2023 Read More
Publications of the Week Targeting the Fibroblast Growth Factor Pathway in Molecular Subtypes of Castration-Resistant Prostate Cancer Labrecque, M., et al. | December 14, 2023 Androgen receptor (AR) pathway inhibition remains the cornerstone for prostate cancer therapies. However, castration-resistant prostate…karnottDecember 14, 2023 Read More
Local News AstraZeneca Will Pay Up to $1.1B to Acquire Icosavax, a University of Washington Biotech Spinout GeekWire | December 13, 2023 Seattle-based Icosavax, a spin-out from the University of Washington’s Institute for Protein Design, will be acquired by…karnottDecember 13, 2023 Read More
Publications of the Week A First-in-Human, Open-Label Phase 1b and a Randomised, Double-Blind Phase 2a Clinical Trial in Recent-Onset Type 1 Diabetes with AG019 As Monotherapy and in Combination with Teplizumab Mathieu, C., et al. | December 13, 2023 We hypothesised that islet beta cell antigen presentation in the gut along with a tolerising…karnottDecember 13, 2023 Read More
Local News ‘1 in 1,000:’ Dr. Sean Gibbons Named Highly Cited Researcher for 2023 Institute for Systems Biology | December 12, 2023 ISB Associate Professor Dr. Sean Gibbons was named a Highly Cited Researcher for 2023. This…karnottDecember 12, 2023 Read More
Local News BBI’s Long-Read Sequencing Symposium Called ‘Inspirational’ Brotman Baty Institute | December 11, 2023 Dr. Danny Miller, the scientific advisor to BBI’s Long Read Sequencing Symposium on November 15,…karnottDecember 11, 2023 Read More